Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

CBO Director May Help Determine Fate Of Health Care
Several newspapers had articles on major players in health care reform. Douglas W. Elmendorf, director of the Congressional Budget Office, has "toiled for much of his career in the anonymous bowels of the nation"s economic superstructure," the Washington Post reports. But now, some lawmakers "think he holds the fate of public policy in his hands." After delivering a "skeptical analysis of a stimulus package intended to rescue the U.S. economy" and forecasting "bigger-than-expected losses from a $700 billion bailout of the U.S. financial system, Elmendorf now "faces the toughest task of his brief tenure: attaching a price to a monumental overhaul of the nation"s health-care system." Sen. Max Baucus, D-Mont., has "publicly lectured Elmendorf, saying he has a moral duty to be "creative" and deliver the favorable budget estimates "we have to have" to win broad support." But Elmendorf says "his office will offer an objective analysis, "without regard to the political consequences."" Elmendorf told the Post that his office would provide the information, but the decision is in the hands of Congress. "CBO is not going to make or break health-care reform," he says.
generic viagra online
Stellar Pharmaceuticals Inc. Announces Watson Pharma, Inc. Has Received A Conditional IDE Approval For Stellar's Uracyst(R) From The FDA
Stellar Pharmaceuticals Inc. ("Stellar" or the "Company") (OTCBB:SLXCF) is pleased to announce that its United States licensee, Watson Pharma, Inc. ("Watson") (NYSE:WPI), has received a conditional approval of their Investigational Device Exemption (IDE) to conduct clinical work with Uracyst® from The Food and Drug Administration (FDA) in the United States of America ("USA"). This will allow Watson to continue to move their Uracyst® development program forward towards the eventual approval for the sale of Uracyst® in USA. The conditional approval allows Watson to begin a blinded, placebo-controlled, pilot clinical trial in 100 subjects at 20 clinical study centers in the USA.
News of the day
A Potential Treatment For Gastric Motility Disorders
GES or pacing has been under investigation as a potential therapy for gastrointestinal motility disorders. Conventionally, GES is performed using a single pair of electrodes or single-channel GES. However, few studies have investigated the effects of two-channel GES with trains of pulses on gastric motility, such as gastric slow waves and gastric emptying.
Public Health

Editorials React To Trustees' Report On Medicare Insolvency

Several newspapers on Thursday published editorials responding to a Medicare trustees report issued Tuesday that said the trust fund Medicare uses to pay for beneficiaries" hospital care will be insolvent by 2017, two years earlier than predicted by trustees last year. Summaries of the editorials appear below. *Akron Beacon Journal: While major health care reform can improve Medicare, Congress should not overlook "that there are changes to Medicare alone that would reap savings, roughly $266 billion a year during the next decade," the editorial says. It adds that President Obama"s proposal to end overpayments to private insurers participating in Medicare Advantage is one such change. The editorial concludes, "Beyond the legislative combat of crafting change, comes the need to pay more (in taxes) or reduce services and benefits" (Akron Beacon Journal, 5/14). *Pittsburgh Post-Gazette: "Possible remedies" to Medicare"s insolvency include "higher premiums, copays and deductibles," a Post-Gazette editorial states. According to the editorial, other ways to aid the program are to reform the health care system "with emphasis on removing excess profits and wasted res" or to make cuts in military spending. The editorial concludes that news of Medicare"s "deteriorating funds" lends "urgency" to reform efforts and "rattle[s] the nerves of the many Americans who depend" on the program (Pittsburgh Post-Gazette, 5/14). *Washington Post: "Even in the face of such bad hews, there are those who will argue against the urgency" of entitlement reform, the editorial states. One argument opponents of reform might use is that Medicare can be fixed only by changing the entire health system, but the editorial says that both the health system and Medicare need "fixing." Politicians have known for years that Social Security and Medicare "are in trouble, ... yet no progress has been made in fixing the programs," the editorial adds. It concludes, "As the trustees highlighted this week, entitlement reform shouldn"t wait" (Washington Post, 5/14). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009